AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 14th, 2017 • BioPharmX Corp • Pharmaceutical preparations
This Amendment to Securities Purchase Agreement (the “Amendment”) is made effective as of April 25, 2017, and amends that certain Securities Purchase Agreement (“Purchase Agreement”) dated as of September 25, 2016 by and among BioPharmX Corporation (“Company”), and the undersigned purchaser identified on the signature pages thereto (the “Purchaser” and, together with the Company, the “Parties”).
